Related Experiment Videos
Therapy for Nb rat tumor transplanted in athymic mice
Journal of Surgical Oncology
|January 1, 1981
Summary
This study shows that BCNU and Actinomycin-D can effectively treat rat prostate cancer models in nude mice. This research validates the use of nude mice models for screening novel cancer therapeutics.
Area of Science:
- Oncology
- Cancer Research
- Pharmacology
Background:
- Prostatic adenocarcinoma is a significant health concern.
- Current treatments for prostate cancer have limitations.
- Novel therapeutic strategies are needed.
Purpose of the Study:
- To evaluate the efficacy of BCNU and Actinomycin-D in treating Nb rat prostatic adenocarcinomas.
- To establish a nude mouse model for screening potential prostate cancer therapeutics.
- To explore agents used for other solid malignancies as potential prostate cancer treatments.
Main Methods:
- Two Nb rat prostatic adenocarcinoma cell lines (13 Pr-12 and 2 Pr-128) were transplanted into athymic nude mice.
- Tumor-bearing mice were treated with BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) and Actinomycin-D.
- Tumor regression and growth inhibition were assessed.
Main Results:
- Both BCNU and Actinomycin-D demonstrated efficacy in producing tumor regression.
- A temporary decrease in tumor growth was observed with both agents.
- The study successfully utilized the rat prostatic adenocarcinoma and nude mouse model.
Conclusions:
- The combination of Nb rat prostatic adenocarcinoma and nude mice is a suitable model for therapeutic agent screening.
- BCNU and Actinomycin-D show promise for treating prostatic adenocarcinoma, warranting further investigation.
- This model can accelerate the discovery of new treatments for prostate cancer by screening agents effective against other solid tumors.